ES2339745T3 - Solucion de irrigacion intraocular que tiene caracteristicas de fluidez mejoradas. - Google Patents
Solucion de irrigacion intraocular que tiene caracteristicas de fluidez mejoradas. Download PDFInfo
- Publication number
- ES2339745T3 ES2339745T3 ES01987379T ES01987379T ES2339745T3 ES 2339745 T3 ES2339745 T3 ES 2339745T3 ES 01987379 T ES01987379 T ES 01987379T ES 01987379 T ES01987379 T ES 01987379T ES 2339745 T3 ES2339745 T3 ES 2339745T3
- Authority
- ES
- Spain
- Prior art keywords
- solution
- viscosity
- intraocular
- solutions
- irrigation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940113601 irrigation solution Drugs 0.000 title claims description 12
- 239000000243 solution Substances 0.000 claims abstract description 80
- 238000001356 surgical procedure Methods 0.000 claims abstract description 29
- 210000001519 tissue Anatomy 0.000 claims abstract description 27
- 210000001742 aqueous humor Anatomy 0.000 claims abstract description 16
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 32
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 32
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 12
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 12
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 7
- 239000003792 electrolyte Substances 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003186 pharmaceutical solution Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 21
- 230000006378 damage Effects 0.000 abstract description 10
- 229940082649 blood substitutes and perfusion irrigating solutions Drugs 0.000 abstract 1
- 239000013010 irrigating solution Substances 0.000 abstract 1
- 230000002262 irrigation Effects 0.000 description 38
- 238000003973 irrigation Methods 0.000 description 38
- 238000000034 method Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 10
- 210000004087 cornea Anatomy 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 208000002177 Cataract Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 210000002889 endothelial cell Anatomy 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 102100028029 SCL-interrupting locus protein Human genes 0.000 description 4
- 239000003855 balanced salt solution Substances 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 210000000871 endothelium corneal Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003190 viscoelastic substance Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- ZTVIKZXZYLEVOL-MCOXGKPRSA-N Homatropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(O)C1=CC=CC=C1 ZTVIKZXZYLEVOL-MCOXGKPRSA-N 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002350 accommodative effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 carboxyvinyl Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 229960000857 homatropine Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25757000P | 2000-12-20 | 2000-12-20 | |
| US257570P | 2000-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2339745T3 true ES2339745T3 (es) | 2010-05-25 |
Family
ID=22976822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01987379T Expired - Lifetime ES2339745T3 (es) | 2000-12-20 | 2001-12-11 | Solucion de irrigacion intraocular que tiene caracteristicas de fluidez mejoradas. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050148542A1 (enExample) |
| EP (1) | EP1343474B1 (enExample) |
| JP (2) | JP2005502581A (enExample) |
| KR (2) | KR100767159B1 (enExample) |
| AT (1) | ATE459337T1 (enExample) |
| AU (2) | AU3960102A (enExample) |
| BR (1) | BR0116353A (enExample) |
| CA (1) | CA2431368C (enExample) |
| CY (1) | CY1110703T1 (enExample) |
| DE (1) | DE60141477D1 (enExample) |
| DK (1) | DK1343474T3 (enExample) |
| ES (1) | ES2339745T3 (enExample) |
| PT (1) | PT1343474E (enExample) |
| TW (1) | TWI290050B (enExample) |
| WO (1) | WO2002049614A2 (enExample) |
| ZA (1) | ZA200303557B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7914803B2 (en) * | 2003-06-13 | 2011-03-29 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of three polymers |
| US7947295B2 (en) | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
| CA2839849C (en) | 2003-06-13 | 2017-03-07 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
| US8372814B2 (en) | 2004-06-07 | 2013-02-12 | Ista Pharmaceuticals, Inc. | Ophthalmic formulations and uses thereof |
| US8748402B2 (en) | 2004-06-07 | 2014-06-10 | Bausch & Lomb Pharma Holdings Corp. | Ophthalmic formulations and uses thereof |
| WO2008011836A2 (es) * | 2006-07-25 | 2008-01-31 | Osmotica Corp. | Soluciones oftálmicas |
| HRP20150097T1 (hr) * | 2008-05-07 | 2015-03-27 | The Regents Of The University Of California | Terapijska nadopuna i poboljšanje vlaženja površine oka |
| EP2555780B1 (en) * | 2010-04-09 | 2016-02-24 | National Health Research Institutes | Gamma-polyglutamic acid-based ocular irrigating solutions |
| JP6588491B2 (ja) * | 2017-03-27 | 2019-10-09 | 東邦瓦斯株式会社 | 潜熱蓄熱材の蓄熱槽内配置方法、及び潜熱蓄熱槽 |
| JP7243549B2 (ja) * | 2019-09-24 | 2023-03-22 | 日油株式会社 | ソフトコンタクトレンズ用タンパク質付着抑制剤およびソフトコンタクトレンズ用溶液、ならびにソフトコンタクトレンズに対するタンパク質の付着を抑制する方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4120949A (en) * | 1977-10-05 | 1978-10-17 | Cooper Laboratories, Inc. | Ophthalmic solution |
| US4328482A (en) * | 1977-11-17 | 1982-05-04 | Consumer Electronic Products Corporation | Remote AC power control with control pulses at the zero crossing of the AC wave |
| US4271143A (en) * | 1978-01-25 | 1981-06-02 | Alcon Laboratories, Inc. | Sustained release ophthalmic drug dosage |
| US4238482A (en) * | 1978-09-29 | 1980-12-09 | Peyman Gholam A | Intraocular infusion irrigation solution and method |
| US4255415A (en) * | 1978-11-22 | 1981-03-10 | Schering Corporation | Polyvinyl alcohol ophthalmic gel |
| JPS5929616A (ja) * | 1982-08-10 | 1984-02-16 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
| US5409904A (en) * | 1984-11-13 | 1995-04-25 | Alcon Laboratories, Inc. | Hyaluronic acid compositions and methods |
| US4886786A (en) * | 1985-08-01 | 1989-12-12 | Lindstrom Richard L | Additive for irrigation solution or surgical solution |
| FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| US5068225A (en) * | 1987-05-04 | 1991-11-26 | Mdr Group, Inc. | Viscoelastic fluid for use in surgery and other therapies and method of using same |
| CA1317226C (en) * | 1987-05-04 | 1993-05-04 | Phillip E. Pennell | Viscoelastic fluid for ophthalmic surgery and method of using same |
| US4983585A (en) * | 1987-05-04 | 1991-01-08 | Mdr Group, Inc. | Viscoelastic fluid for use in surgery and other therapies and method of using same |
| US6271216B1 (en) * | 1989-07-24 | 2001-08-07 | Allergan | Stable solution of hyaluronate in a balanced salt medium |
| CA2086014A1 (en) * | 1990-07-03 | 1992-01-04 | CHARLES D. kELMAN | Collagen-based viscoelastic solution for visco-surgery |
| JPH0665061A (ja) * | 1991-06-25 | 1994-03-08 | L Lyndstrom Richard | 洗浄溶液並びに外科用溶液の添加剤 |
| US5328701A (en) * | 1992-09-10 | 1994-07-12 | Peregrine Surgical Ltd. | Tissue irrigation solution |
| US5895645A (en) * | 1995-01-31 | 1999-04-20 | Bausch & Lomb Incorporated | Opthalmic solution for artificial tears |
| JP4167728B2 (ja) * | 1996-02-07 | 2008-10-22 | ロート製薬株式会社 | 粘度を調節した眼科用組成物 |
| BR9806626A (pt) * | 1997-03-10 | 2001-03-20 | Galvak S A De C V | Método e aparelho para operar um sistema para galvanizar lâmina de aço |
| DE69818675T2 (de) * | 1997-07-29 | 2004-07-29 | Alcon Laboratories, Inc., Fort Worth | Galaktomannanpolymere und borat enthaltende augenarzneimittel |
| US6174524B1 (en) * | 1999-03-26 | 2001-01-16 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
| US7084130B2 (en) * | 2001-12-11 | 2006-08-01 | Alcon, Inc. | Intraocular irrigating solution having improved flow characteristics |
| US6878694B2 (en) * | 2000-12-20 | 2005-04-12 | Alcon, Inc. | Ophthalmic irrigating solution adapted for use in lasik surgery |
| WO2002049611A2 (en) * | 2000-12-20 | 2002-06-27 | Alcon, Inc. | Ophthalmic lubricating solution adapted for use in lasik surgery |
-
2001
- 2001-12-11 AU AU3960102A patent/AU3960102A/xx active Pending
- 2001-12-11 KR KR1020037008262A patent/KR100767159B1/ko not_active Expired - Fee Related
- 2001-12-11 ES ES01987379T patent/ES2339745T3/es not_active Expired - Lifetime
- 2001-12-11 DE DE60141477T patent/DE60141477D1/de not_active Expired - Lifetime
- 2001-12-11 BR BR0116353-1A patent/BR0116353A/pt not_active Application Discontinuation
- 2001-12-11 PT PT01987379T patent/PT1343474E/pt unknown
- 2001-12-11 AU AU2002239601A patent/AU2002239601B2/en not_active Ceased
- 2001-12-11 CA CA002431368A patent/CA2431368C/en not_active Expired - Lifetime
- 2001-12-11 EP EP01987379A patent/EP1343474B1/en not_active Expired - Lifetime
- 2001-12-11 DK DK01987379.3T patent/DK1343474T3/da active
- 2001-12-11 AT AT01987379T patent/ATE459337T1/de active
- 2001-12-11 KR KR1020077017978A patent/KR20070087252A/ko not_active Ceased
- 2001-12-11 WO PCT/US2001/048094 patent/WO2002049614A2/en not_active Ceased
- 2001-12-11 JP JP2002550956A patent/JP2005502581A/ja active Pending
- 2001-12-19 TW TW090131545A patent/TWI290050B/zh not_active IP Right Cessation
-
2003
- 2003-05-08 ZA ZA2003/03557A patent/ZA200303557B/en unknown
-
2005
- 2005-02-11 US US11/056,042 patent/US20050148542A1/en not_active Abandoned
-
2007
- 2007-10-04 US US11/867,523 patent/US20080020017A1/en not_active Abandoned
-
2008
- 2008-07-08 JP JP2008177713A patent/JP2008308503A/ja active Pending
-
2010
- 2010-03-19 CY CY20101100252T patent/CY1110703T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20080020017A1 (en) | 2008-01-24 |
| US20050148542A1 (en) | 2005-07-07 |
| DK1343474T3 (da) | 2010-05-17 |
| CY1110703T1 (el) | 2015-06-10 |
| PT1343474E (pt) | 2010-04-19 |
| ZA200303557B (en) | 2005-05-25 |
| KR20070087252A (ko) | 2007-08-27 |
| AU3960102A (en) | 2002-07-01 |
| JP2008308503A (ja) | 2008-12-25 |
| TWI290050B (en) | 2007-11-21 |
| JP2005502581A (ja) | 2005-01-27 |
| WO2002049614A2 (en) | 2002-06-27 |
| EP1343474B1 (en) | 2010-03-03 |
| DE60141477D1 (de) | 2010-04-15 |
| KR20030063441A (ko) | 2003-07-28 |
| HK1055251A1 (en) | 2004-01-02 |
| CA2431368C (en) | 2006-08-08 |
| WO2002049614A3 (en) | 2003-01-23 |
| BR0116353A (pt) | 2005-04-05 |
| EP1343474A2 (en) | 2003-09-17 |
| CA2431368A1 (en) | 2002-06-27 |
| KR100767159B1 (ko) | 2007-10-15 |
| AU2002239601B2 (en) | 2005-09-01 |
| ATE459337T1 (de) | 2010-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4146910B2 (ja) | 眼外科用のヒアルロン酸ナトリウム主薬の眼製剤 | |
| US20080020017A1 (en) | Intraocular Irrigating Solution Having Improved Flow Characteristics | |
| US7084130B2 (en) | Intraocular irrigating solution having improved flow characteristics | |
| ES2797776T3 (es) | Un dispositivo quirúrgico oftálmico | |
| ES2236890T3 (es) | Composicion oftalmica. | |
| US9504605B2 (en) | Lacrimal filler | |
| Shettigar et al. | Vitreous substitutes and tamponades–A review of types, applications, and future directions | |
| US7363928B2 (en) | Dilution resistant viscoelastic compositions | |
| US7578809B2 (en) | Surface modified viscoelastics for ocular surgery | |
| US20060003964A1 (en) | Dilution resistant viscoelastic compositions | |
| HK1055251B (en) | Intraocular irrigating solution having improved flow characteristics | |
| Pandey et al. | Update on ophthalmic viscosurgical devices | |
| US20090258955A1 (en) | Intraocular irrigating solution having improved flow characteristics | |
| Cheng et al. | Case series and review article: perfluorocarbon heavy liquid as a short-term tamponade after vitrectomy for inferior rhegmatogenous retinal detachment | |
| Schepens | Vitreous substitutes and vitreous surgery | |
| Capone Jr et al. | Pedro F. Lopez and Barry A. Mandell Retina Service, Department of Ophthalmology, Emory University, Atlanta, Georgia, USA | |
| WO2025005896A1 (en) | Ophthalmic viscoelastic formulations suitable for use in cataract surgery | |
| Kamboj et al. | Phacoemulsification in Eyes with Corneal Diseases | |
| Garg | Update on Ophthalmic Viscosurgical Devices | |
| Rawal | Vitreous Substitutes | |
| Ahmed et al. | Comparison of two ophthalmic viscosurgical devices used in Phaecoemulsification | |
| Dick et al. | Special Uses of Viscoelastics | |
| Rand et al. | CATARACT SURGERY IN PSEUDOEXFOLIATION SYNDROME | |
| HK1029929B (en) | Opthalmic composition |